At the start of my career, I strengthened my scientific foundation through deep involvement in translational preclinical academic research as a Research Engineer.

This period allowed me to develop a solid experimental and technical background, and to understand the principles of methodological rigor and systemic approaches that underpin successful biomedical R&D projects.

​

This initial experience was later complemented by certified professional training, enabling me to better grasp the challenges of pharmaceutical development and clinical research.

That transition laid the groundwork for a cross-disciplinary career spanning both preclinical and clinical domains.

Over the years, I strengthened my expertise within the pharmaceutical industry and consulting, deepening my mastery of international regulatory and clinical affairs throughout the entire healthcare product lifecycle, from preclinical to post-market.

​

These experiences, across drugs, medical devices, rare diseases, neurology, and oncology, helped me understand the interconnections between regulatory, clinical, and scientific aspects and industrial operations.

I learned to anticipate regulatory impacts, structure submission strategies, and ensure global compliance for numerous healthcare products.

​

Today, this holistic approach lies at the core of my professional practice.

Throughout my career, I’ve also had the opportunity to engage in European research consortia, where I contributed to collective reflections on clinical research and therapeutic innovation regulation, particularly in the field of rare diseases.

​

This experience enriched my understanding of institutional dynamics, European policy frameworks, and the real needs of stakeholders -  researchers, clinicians, industry professionals, and patients alike.